Functional outcome and histologic analysis of late onset total type brachial plexus injury treated with intercostal nerve transfer to median nerve with local umbilical cord-derived mesenchymal stem cells or secretome injection: a double-blinded, randomized control study
European Journal of Orthopaedic Surgery & Traumatology · 2024
DOI: 10.1007/s00590-024-04110-6 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2024. Verfasst von Wahyu Widodo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. wahyu.widodo01@ui.ac.id. Hauptthemen laut MEDLINE: Nerve Transfer, Intercostal Nerves, Mesenchymal Stem Cell Transplantation, Median Nerve. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Badan Riset dan Inovasi Nasional.
Abstract (Originalsprache)
INTRODUCTION: Intercostal nerve transfer is a surgical technique used to restore function in patients with total brachial plexus injury. Stem cell and secretome therapy has been explored as a potential treatment for brachial plexus injuries. This study aimed to compare the functional and histologic outcome of intercostal nerve transfer to median nerve with local stem cells or secretome injection in total type brachial plexus injuries. MATERIALS AND METHODS: This was a double-blinded, randomized controlled study (RCT). We included patients with neglected total type brachial plexus injury (BPI) who underwent nerve transfer and local injection of either umbilical cord-derived mesenchymal stem cells (UC-MSC) or secretome into median nerve-flexor digitorum superficialis (FDS) neuromuscular junction (NMJ). We measured preoperative and 8-month postoperative FDS muscle strength, SF-36, DASH score, and histologic assessment. We then analyzed the difference outcome between those two groups. RESULT: A total of 15 patients were included in this study. Our study found that after nerve transfer and implantation with either UC-MSC or secretome, significant postoperative improvements were observed in physical functioning, role limitations, energy/fatigue, emotional well-being, social functioning, pain, general health, and DASH scores, particularly in the overall cohort and the secretome group. When we compared the mean difference of clinical outcome from preoperative to postoperative between UC-MSC and secretome groups, the UC-MSC group showed better improvement of health change in SF-36 subgroup compared to secretome group. From the analysis, there was no significant difference in the histologic outcomes (inflammation, regeneration, and fibrosis) in overall cohort between preoperative and postoperative cohort. There was also no significant difference in mean change of the histologic outcomes (inflammation, regeneration, and fibrosis) preoperative and postoperatively between UC-MSC and secretome groups. DISCUSSION AND CONCLUSION: Implantation of either UC-MSC or secretome along with nerve transfer may provide clinical improvement, while to achieve histologic improvement, further conditioning should be performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral Program in Medical Sciences Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. wahyu.widodo01@ui.ac.id.
- Orthopedic and Traumatology Department, Cipto Mangunkusumo National Central Public Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. wahyu.widodo01@ui.ac.id.
- Orthopedic and Traumatology Department, Fatmawati General Hospital, Jakarta, Indonesia. wahyu.widodo01@ui.ac.id.
- Orthopedic and Traumatology Department, Cipto Mangunkusumo National Central Public Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Histology Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Stem Cell and Tissue Engineering Research Cluster IMERI, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Förderung
- Badan Riset dan Inovasi Nasional
Zitieren
APA
Widodo, W., Dilogo, I. H., Kamal, A. F., Antarianto, R. D., Wuyung, P. E., Siregar, N. C., Octaviana, F., Kekalih, A., Suroto, H., Latief, W., & Hutami, W. D. (2024). Functional outcome and histologic analysis of late onset total type brachial plexus injury treated with intercostal nerve transfer to median nerve with local umbilical cord-derived mesenchymal stem cells or secretome injection: a double-blinded, randomized control study. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-024-04110-6
Vancouver
Widodo W, Dilogo IH, Kamal AF, Antarianto RD, Wuyung PE, Siregar NC, et al. Functional outcome and histologic analysis of late onset total type brachial plexus injury treated with intercostal nerve transfer to median nerve with local umbilical cord-derived mesenchymal stem cells or secretome injection: a double-blinded, randomized control study. European Journal of Orthopaedic Surgery & Traumatology. 2024. doi:10.1007/s00590-024-04110-6
BibTeX
@article{Widodo2024,
author = {Widodo, Wahyu and Dilogo, Ismail Hadisoebroto and Kamal, Achmad Fauzi and Antarianto, Radiana Dhewayani and Wuyung, Puspita Eka and Siregar, Nurjati Chairani and Octaviana, Fitri and Kekalih, Aria and Suroto, Heri and Latief, Wildan and Hutami, Witantra Dhamar},
title = {Functional outcome and histologic analysis of late onset total type brachial plexus injury treated with intercostal nerve transfer to median nerve with local umbilical cord-derived mesenchymal stem cells or secretome injection: a double-blinded, randomized control study},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
doi = {10.1007/s00590-024-04110-6}
}
EUVIMED